Finanzen von Portage Biotech Inc (PRTG)PRTGPortage Biotech Inc

Evaluating the bottom line, AlphaTON Capital Corp maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -347.11%, provide a clear picture of how effectively PRTG converts its operational activities into shareholder value.

In the context of the broader market, PRTG competes directly with industry leaders such as CMMB and OSRH. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, PRTG's gross margin of N/A stands against CMMB's N/A and OSRH's 27.44%. Such benchmarking helps identify whether AlphaTON Capital Corp is trading at a premium or discount relative to its financial performance.